Novanta stock kpis
Want to see NOVT full AI Analyst Report?
Operating Income by Segment
Novanta reported operating income by segment of $18.06M in Q2 2026, down 34.4% from Q1 2026 and up 21.1% year over year. The highest value was $32.55M in Q3 2024.
Measures operating profit after segment-level operating costs, showing which divisions contribute real operating earnings versus those that may be loss-making after overhead. Useful for spotting units that need restructuring or additional investment and for understanding the sustainability of consolidated profits.
Operating income shows a structural shift: since 2024 the profit engine has moved away from Robotics and Precision Medicine into a newly dominant Automation Enabling Technologies cluster, validating management’s push into AI-driven robotics and new-product design wins. Medical Solutions still contributes but is more volatile, while rising unallocated overhead is a steady drag on consolidated profitability. That mix creates upside from automation tailwinds and design-win momentum but keeps execution risk in precision medicine and margin pressure from higher corporate costs.
NOVT Operating Income by Segment
| Period | Unallocated | Precisions Medicine & Manufacturing | Medical Solutions | Automation Enabling Technologies | Robotics & Automation | Total |
|---|---|---|---|---|---|---|
| Q2 2026Jul 03, 2026 | -$32.14M | $0.00 | $13.61M | $36.59M | $0.00 | $18.06M |
| Q1 2026Apr 03, 2026 | -$20.34M | $0.00 | $16.73M | $31.15M | $0.00 | $27.54M |
| Q4 2025Dec 31, 2025 | -$18.59M | $0.00 | $14.60M | $28.82M | $0.00 | $24.83M |
| Q3 2025Sep 26, 2025 | -$21.42M | $0.00 | $15.92M | $27.35M | $0.00 | $21.85M |
| Q2 2025Jun 27, 2025 | -$18.59M | $0.00 | $6.63M | $26.87M | $0.00 | $14.91M |
| Q1 2025Mar 28, 2025 | -$13.10M | $0.00 | $14.03M | $31.49M | $0.00 | $32.42M |
| Q4 2024Dec 31, 2024 | -$11.22M | $0.00 | $7.04M | $30.89M | $0.00 | $26.71M |
| Q3 2024Sep 27, 2024 | -$13.83M | $0.00 | $16.32M | $30.06M | $0.00 | $32.55M |
| Q2 2024Jun 28, 2024 | -$13.95M | $0.00 | $18.15M | $21.52M | $0.00 | $25.71M |
| Q1 2024Mar 29, 2024 | -$14.34M | $0.00 | $16.02M | $23.93M | $0.00 | $25.61M |
| Q4 2023Dec 31, 2023 | -$12.63M | $14.48M | $10.91M | $0.00 | $8.92M | $21.68M |
| Q3 2023Sep 29, 2023 | -$11.46M | $18.51M | $11.05M | $0.00 | $12.21M | $30.31M |
| Q2 2023Jun 30, 2023 | -$12.74M | $19.61M | $10.08M | $0.00 | $15.25M | $32.20M |
| Q4 2022Dec 31, 2022 | -$10.64M | $18.98M | $7.43M | $0.00 | $12.07M | $27.84M |
| Q3 2022Sep 30, 2022 | -$14.23M | $18.35M | $8.74M | $0.00 | $15.80M | $28.66M |
| Q2 2022Jul 01, 2022 | -$11.81M | $14.00M | $7.02M | $0.00 | $14.08M | $23.29M |
| Q1 2022Apr 01, 2022 | -$12.53M | $13.44M | $5.04M | $0.00 | $18.34M | $24.28M |
| Q4 2021Dec 31, 2021 | -$12.73M | $10.91M | $5.52M | $0.00 | $17.99M | $21.69M |
| Q3 2021Oct 01, 2021 | -$14.58M | $9.29M | $5.61M | $0.00 | $14.96M | $15.28M |
| Q2 2021Jul 02, 2021 | -$13.69M | $14.20M | $3.21M | $0.00 | $12.28M | $15.99M |
| Q1 2021Apr 02, 2021 | -$12.11M | $12.39M | $3.37M | $0.00 | $7.45M | $11.10M |
| Q1 2021Mar 31, 2021 | -$12.21M | $16.68M | $9.84M | $0.00 | $12.00M | $26.31M |

